Intellia Therapeutics NTLA Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's increase (decrease) in prepaid expense and other assets?
- Intellia Therapeutics (NTLA) reported increase (decrease) in prepaid expense and other assets of $12.97M in Q1 2026.
- How has Intellia Therapeutics's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Intellia Therapeutics's increase (decrease) in prepaid expense and other assets increased by 6050.5% year-over-year, from -$218K to $12.97M.
- What is the long-term trend for Intellia Therapeutics's increase (decrease) in prepaid expense and other assets?
- Over 3 years (2022 to 2025), Intellia Therapeutics's increase (decrease) in prepaid expense and other assets has grown at a 130.2% compound annual growth rate (CAGR), from $2.16M to $26.35M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.